- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06582147
The Social Determinants of Health Screening and Referral Project
Implementing a Social Determinants of Health Screening and Referral Care Model in the Neonatal Intensive Care Unit
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The goal of this study is to implement SDOH screening and referral models in 7 safety net NICUs, examining their potential to offset the effects of adverse SDOH for a highly vulnerable population at the earliest stages of life. The investigators propose a hybrid effectiveness-implementation stepped wedge cluster randomized trial using the Proctor Conceptual Model of Implementation Research. The investigators will follow a cohort of 882 mother-infant dyads longitudinally for 12 months after NICU discharge to examine family, maternal, and infant outcomes. Each site will participate in three phases: usual, experimental, and sustainment.
The study aims are to:
Aim 1: Examine the implementation of SDOH screening and referral models into the NICU (acceptability, feasibility, penetration, equity, and sustainability).
Aim 2: Examine the effectiveness and equity of SDOH screening and referral models in the NICU setting on parental receipt of community resources for unmet social needs 3 months post-NICU discharge.
Aim 3: Explore the effectiveness of SDOH screening and referral models in the NICU to improve (a) maternal mental health (depression) and (b) health and developmental outcomes of preterm infants (quality of life, growth, development, and respiratory disease) during the 12 months post-NICU discharge.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Denver, Colorado, United States, 80204
- Denver Health Hospital Authority
-
-
Florida
-
Jacksonville, Florida, United States, 32209
- Shands Jacksonville Medical Center, Inc. DBA UF Health Jacksonville
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Children's Hospital of Michigan
-
-
Mississippi
-
Jackson, Mississippi, United States, 39216
- University of Mississippi Medical Center
-
-
New York
-
Bronx, New York, United States, 10467
- Children's Hospital at Montefiore
-
-
Ohio
-
Cincinnati, Ohio, United States, 45229
- Cincinnati Children's Hospital Medical Center
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19140
- Temple University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Infant gestational age <34 weeks' gestation; singleton or multiple.
- Infant hospitalized for at least 14 days of life (to allow for SDOH screening/referral and contact with resources if applicable).
- Mother and infant are alive.
- Mother speaks and reads English or Spanish.
- Infant will be discharged home from the NICU (to allow for follow-up).
- Mother will care for her infant(s) at home in the US for at least 12 months after discharge from the NICU.
Exclusion Criteria:
- Mothers or infants who die before anticipated infant discharge.
- Infant discharged after 52 weeks postmenstrual age.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Social needs screening and referral care
As a step wedge cluster randomized trial all sites will be assigned to receive the intervention in a randomized order.
There is no difference in the intervention by site, the only difference is the timing of the beginning of the intervention.
Therefore, we have only identified one arm.
|
WE CARE is a relatively simple, low-intensity intervention that has two key components: (1) screening individuals using the WE CARE SDOH Screener for unmet social needs, and (2) providing individuals who have unmet social needs with SDOH Community Resource sheets
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Penetration of SDOH intervention
Time Frame: Monthly for approximately 12 months
|
Penetration is the rate of administration of social needs screener and appropriate referral for community resources to eligible families.
|
Monthly for approximately 12 months
|
|
Receipt of ANY Community Resource
Time Frame: 3 months Post-NICU discharge
|
Receipt of any community resource as collected via participant survey specifying receipt of the resource.
|
3 months Post-NICU discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sustainability of SDOH intervention
Time Frame: Monthly for approximately 6 months.
|
Number of individuals who continued to get screened after active intervention is complete.
|
Monthly for approximately 6 months.
|
|
Equity of implementation
Time Frame: Monthly for approximately 18 months (during both penetration and sustainability).
|
Penetration rate by maternal demographics.
|
Monthly for approximately 18 months (during both penetration and sustainability).
|
|
Equity of receipt of community resources
Time Frame: 3 months Post-NICU discharge
|
Rate of receipt of community resources by maternal demographics
|
3 months Post-NICU discharge
|
|
SDOH Risk
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
Any social need or change in social need for housing, food, utilities, childcare, employment, transportation, or education was collected via participant survey.
|
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
|
SDOH Desire Assistance
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
Any desired assistance or change in desired assistance for housing, food, utilities, childcare, employment, transportation, and education was collected via participant survey.
|
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
|
SDOH Community Resource
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
Number of individuals who received any community resource (housing, food, utilities, education, employment, childcare, transportation).
|
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
|
Maternal Wellbeing
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
Rating of current overall health
|
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
|
Postpartum maternal primary care utilization
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
|
Number of appointments with a primary care provider
|
3 months, 6 months, and 12 months Post-NICU discharge
|
|
Maternal Postpartum Obstetric Care Utilization
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
|
Number of appointments with a maternal postpartum obstetric provider
|
3 months, 6 months, and 12 months Post-NICU discharge
|
|
Maternal emergency room utilization
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
|
Number of emergency room visits.
|
3 months, 6 months, and 12 months Post-NICU discharge
|
|
Maternal hospital readmission
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
|
Number of overnight hospital readmissions
|
3 months, 6 months, and 12 months Post-NICU discharge
|
|
Maternal Depression
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
Overall score on Personal Health Questionnaire Depression Scale (PHQ8), an 8-item instrument with 4 category Likert scale responses from 0 to 4 where 0=not at all and 4=daily.
Scores can range from 0 to 32.
Higher scores are associated with greater levels of maternal depression.
|
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
|
Length of Lactation
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
Duration of milk production in months
|
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
|
Infant primary care utilization
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
|
Number of appointments with a primary care provider
|
3 months, 6 months, and 12 months Post-NICU discharge
|
|
Infant utilization of emergency care
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
|
Number of emergency room visits
|
3 months, 6 months, and 12 months Post-NICU discharge
|
|
Infant hospital readmission
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
|
Number of overnight hospital readmissions
|
3 months, 6 months, and 12 months Post-NICU discharge
|
|
Receipt of necessary infant services and equipment
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
|
The proportion of individuals who receive services and equipment among those individuals who indicate needing services and equipment on the national survey of children with special healthcare needs
|
3 months, 6 months, and 12 months Post-NICU discharge
|
|
Infant Respiratory Symptoms (shortness of breath, wheezing, coughing, clinically demonstrated need for oral corticosteroids)
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
|
Overall score on Test for Respiratory and Asthma Control in Kids.
Each item is scored from 0 to 20 points on a 5-point Likert-type scale for a total score ranging from 0 to 100.
Higher scores indicate better respiratory control.
|
3 months, 6 months, and 12 months Post-NICU discharge
|
|
Infant growth
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
Weight for age z-score change
|
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
|
Infant Quality of Life
Time Frame: 3 months, 6 months, and 12 months Post-NICU discharge
|
Overall score on the Infant Toddler Quality of Life Questionnaire™ (ITQOL) is a 47-item short form that is scored on a scale from 0 (worst health) to 100 (best health).
Higher scores indicate a better quality of life.
|
3 months, 6 months, and 12 months Post-NICU discharge
|
|
Acceptability of SDOH intervention
Time Frame: Approximately 7, 9, and 12 months
|
Mean score on Acceptability of Intervention Measure (AIM), which is a 4-item measure of perceived intervention acceptability.
Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree).
The score is calculated mean, and higher scores are associated with better acceptability.
(Minimum score is 4, maximum score is 20).
|
Approximately 7, 9, and 12 months
|
|
Feasibility of SDOH intervention
Time Frame: Approximately 7, 9, and 12 months.
|
Mean score on Feasibility of Intervention Measure (FIM) is A 4-item instrument to assess perceived intervention feasibility.
Items are measured on a 5-point Likert scale (Completely Disagree-Completely Agree).
Score is calculated mean, and higher scores are associated with better feasibility.
(Minimum score is 4, maximum score is 20).
|
Approximately 7, 9, and 12 months.
|
|
Family Economic Pressure
Time Frame: Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
The Family Economic Pressure scale is a 2-item measure that is scored and summed together.
Scores on Measures A and B are from the Economic Pressure Scale.
Higher levels indicate higher economic hardship.
(Minimum score is 6, maximum score is 30).
|
Baseline, 3 months, 6 months, and 12 months Post-NICU discharge
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Margaret Parker, MD, MPH, University of Massachusetts Chan Medical School
- Principal Investigator: Mari-Lynn Drainoni, PhD, MEd, Boston University Chobanian and Avedisian School of Medicine
- Principal Investigator: Arvin Garg, MD, MPH, University of Massachusetts Chan Medical School
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00000543
- 5R01HD104772 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Birth
-
University of WashingtonRecruitingVery Preterm and Extremely Preterm BirthUnited States
-
Federico II UniversityRecruiting
-
University of OxfordShoklo Malaria Research UnitCompleted
-
Thomas Jefferson UniversityCompleted
-
Chelsea and Westminster NHS Foundation TrustSPD Development Company Limited; Borne CharityRecruitingPreterm Birth | Preterm Labor | Preterm Birth Complication | Preterm Premature Rupture of Membrane | Preterm PregnancyUnited Kingdom
-
Cairo UniversityCompleted
-
University of OklahomaCompletedPreTerm Birth | PreTerm NeonateUnited States
-
PreTeL, IncDuke University; University of RochesterRecruitingPreterm Birth | Threatened Preterm Labor | PreTerm LaborUnited States
-
Eunice Kennedy Shriver National Institute of Child...CompletedPregnancy | Preterm Birth | Preterm LaborUnited States
-
University Hospital Inselspital, BerneAmniSure International LLCCompletedPreterm Birth | Preterm LabourSwitzerland
Clinical Trials on Implementation of social determinants of health screening and referral
-
Barbara Ann Karmanos Cancer InstituteRecruitingCancer | Neuroendocrine Tumors | Cancer Survivors | Gastrointestinal Cancers | Multiple Myeloma, NeoplasmsUnited States
-
Hackensack Meridian HealthBecton, Dickinson and CompanyCompleted
-
Abramson Cancer Center at Penn MedicineGilead SciencesActive, not recruitingBreast Cancer | Social Determinants of Health (SDOH)United States
-
Canadian Cancer Trials GroupRecruiting
-
University of Toledo Health Science CampusCompletedQuality of Life | Patient Satisfaction | Social Determinants of HealthUnited States
-
M.D. Anderson Cancer CenterRecruitingTransplant and Cell TherapyUnited States
-
Indiana UniversityRecruitingMetastatic Cancer | Advanced CancerUnited States
-
University of HawaiiNational Heart, Lung, and Blood Institute (NHLBI); National Association of... and other collaboratorsCompletedHypertension | Type 2 Diabetes Mellitus | Dyslipidemia | Pre-diabetes | Cardiometabolic Syndrome | Weight Loss TrialUnited States
-
Abramson Cancer Center at Penn MedicineAmerican Heart AssociationActive, not recruitingCardiovascular Diseases | Prostate Cancer | Drug-Related Side Effects and Adverse Reactions | CardiotoxicityUnited States
-
Abramson Cancer Center at Penn MedicineAmerican Heart AssociationActive, not recruitingCardiovascular Diseases | Breast Cancer | Drug-Related Side Effects and Adverse Reactions | CardiotoxicityUnited States